This effect of adiponectin on insulin resistance appears to be mediated, at least in part, by an increase in fatty acid oxidation through activation of AMP-activated protein kinase (AMPK) and also through the peroxisome proliferator-activated receptor (PPAR)-α in the muscles and liver [49,50,51,52,53]. The gene discussed is ADIPOQ; the disease is Insulin resistance.